Molecular system bioenergetics: Regulation of substrate supply in response to heart energy demands

Journal of Physiology

Volumn 577, Issue 3, 2006, Pages 769-777

  Saks, Valdur A ^a,b   Favier, Roland ^a   Guzun, Rita ^a   Schlattner, Uwe ^a   Wallimann, Theo ^c  

^a INSERM   (France)

^b National Institute of Chemical and Biological Physics   (Estonia)

^c ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ADENYLATE KINASE; MALONYL COENZYME A; ACYL COENZYME A; GLUCOSE;

AEROBIC METABOLISM; CITRIC ACID CYCLE; ENERGY CONSUMPTION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FATTY ACID OXIDATION; FEEDBACK SYSTEM; GLUCOSE OXIDATION; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART WORK; HUMAN; ISOLATED HEART; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ARTICLE; BIOENERGY; ENERGY RESOURCE; ENZYME ASSAY; HEART ENERGY DEMAND; HEART MUSCLE; METABOLIC RATE; METABOLIC REGULATION; MOLECULAR DYNAMICS; PHYSICAL PHENOMENA; STEADY STATE; WORKLOAD;

ANIMALS; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HUMANS; MUSCLE, SKELETAL; MYOCARDIUM; OXIDATION-REDUCTION;

EID: 33845335159     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.120584     Document Type: Review

References (59)

1. Assifi MM, Suchankova G, Constant S, Prentki M, Saha AK & Ruderman NB (2005). AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. Am J Physiol Endocrinol Metab 289, E794-E800.
2. Balaban RS & Heineman FW (1989). Interaction of oxidative phosphorylation and work in the heart in vivo. News Physiol Sci 4, 215-218.
3. Balaban RS, Kantor HL, Katz LA & Briggs RW (1986). Relation between work and phosphate metabolites in the in vivo paced mammalian heart. Science 232, 1121-1123.
4. Beauloye C, Marsin AS, Bertrand L, Vanoverschelde JL, Rider MH & Hue L (2002). The stimulation of heart glycolysis by increased workload does not require AMP activated protein kinase but a wortmannin-sensitive mechanism. FEBS Lett 531, 324-328.
5. Bing RJ (1965). Cardiac metabolism. Physiol Rev 45, 171-213.
6. Bing RJ, Siegel A, Ungar I & Gilbert M (1954). Metabolism of the human heart. II. Metabolism of fats, proteins and ketones. Am J Med 16, 504.
7. Bose S, French S, Evans FJ, Joubert F & Balaban RS (2003). Metabolic network control of oxidative phosphorylation: Multiple roles of inorganic phosphate. J Biol Chem 278, 39155-39165.
8. Brandes R & Bers DM (1999). Analysis of the mechanisms of mitochondrial NADH regulation in cardiac trabeculae. Biophys J 77, 1666-1682.
9. Clark AJ, Graddie R & Stewart CP (1931). The metabolism of the isolated heart of the frog. J Physiol 72, 443-466.
10. Cuthbert KD & Dyck JR (2005). Malonyl-CoA decarboxylase is a major regulator of myocardial fatty acid oxidation. Curr Hyertens Report 7, 407-411.
11. Dagher Z, Ruderman N, Tornheim K & Ido Y (2001). Acute regulation of fatty acid oxidation and amp-activated protein kinase in human umbilical vein endothelial cells. Circ Res 88, 1276-1282.
12. DiLisa F, Barbato R, Menabo R & Siliprandi N (1995). Carnitine and carnitine esters in mitochondrial metabolism and function. In The Carnitine System: A New Therapeutical Approach to Cardiovascular Diseases, ed. DeJong JW & Ferrari R, pp. 21-38. Kluwer Academic Publishers, Dordrecht, Boston, London.
13. Dyck J & Lopaschuk GD (2006). AMPK alterations in cardiac physiology and pathology: Enemy or ally? J Physiol 574, 95-112.
14. Dyck JR & Lopaschuk GD (2002). Malonyl CoA control of fatty acid oxidation in the ischemic heart. J Mol Cell Cardiol 34, 1099-1109.
15. Fritz IB & Marquis NR (1965). The role of acylcarnitine esters and carnitine palmityltransferase in the transport of fatty acyl groups across mitochondrial membranes. Proc Natl Acad Sci U S A 54, 1226-1233.
16. Goodwin GW & Taegtmeyer H (1999). Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation. Am J Physiol Endocrinol Metab 277, E772-E777.
17. Hardie DG & Sakamoto K (2006). AMPK: A key sensor of fuel and energy status in skeletal muscle. Physiology 21, 48-60.
18. Hassinen IE (1986). Mitochondrial respiratory control in the myocardium. Biochim Biophys Acta 853, 135-151.
19. Hassinen IE & Hiltunen K (1975). Respiratory control in isolated perfused rat heart. Role of the equilibrium relations between the mitochondrial electron carriers and the adenylate system. Biochim Biophys Acta 408, 319-330.
20. Holloway GP, Bezaraire V, Heigenhauser GJF, Tandon NN, Glatz Luiken JJFP, Bonen A & Spriet LL (2006). Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J Physiol 571, 201-210.
21. Jorgensen SB, Richter EA & Wojtaszewski JFP (2006). Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise. J Physiol 574, 17-31.
22. Kiens B (2006). Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev 86, 205-243.
23. King KL, Okere IC, Sharma N, Dyck JRB, Reszko AE, McElfresh TA, Kerner J, Chandler MP, Lopaschuk G & Stanley WC (2005). Regulation of manonyl-CoA content and fatty acid oxidation during increased cardiac power. Am J Physiol 289, H1033-H1037.
24. Kitano H (2002). Systems biology: A brief overview. Science 295, 1662-1664.
25. Kobayashi K & Neely JR (1979). Control of maximum rates of glycolysis in rat cardiac muscle. Circ Res 4, 166-175.
26. Korge P, Honda HM & Weiss JN (2003). Effects of fatty acids in isolated mitochondria: Implications for ischemic injury and cardioprotection. Am J Physiol Heart Circ Physiol 285, H259-H269.
27. Kudo N, Gillespie JG, Kung L, Witters LA, Schulz R, Clanachan AS & Lopaschuk GDA (1996). Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta 1301, 67-75.
28. Kushmerick MJ, Meyer RA & Brown TR (1992). Regulation of oxygen consumption in fast- and slow-twitch muscle. Am J Physiol Cell Physiol 263, C598-C606.
29. Lee M, Hwang JT, Yun H, Kim EJ, Kim MJ, Kim SS & Ha J (2006). Critical roles of AMP-activated protein kinase in the carcinogenic metal-induced expression of VEGF and HIF-1 proteins in DU145 prostate carcinoma. Biochem Pharmacol 72, 91-103.
30. Lysiak W, Lilly K, DiLisa F, Toth P & Bieber LL (1988). Quantitation of the effect of L-carnitine on the levels of acid-soluble short-chain acyl-CoA and CoASH in rat heart and liver mitochondria. J Biol Chem 263, 1151-1156.
31. Marquis NR & Fritz IB (1965). The distribution of carnitine, acetylcarnitine and carnitine acetyltransferase in rat tissues. J Biol Chem 240, 2193-2196.
32. Merrill GF, Kurth EJ, Hardie DG & Winder WW (1997). AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol Endocrinol Metab 273, E1107-E1112.
33. Neely JR, Denton RM, England PJ & Randle PJ (1972). The effects of increased heart work on the tricarboxylate cycle and its interactions with glycolysis in the perfused rat heart. Biochem J 128, 147-159.
34. Neely JR & Morgan HE (1974). Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 63, 413-459.
35. Nicholls D & Ferguson SJ (2002). Bioenergetics. Academic Press, London, New York.
36. Noble D (2002). Modeling the heart -from genes to cells to the whole organ. Science 295, 1678-1682.
37. Nuutinen EM, Peuhkurinen KJ, Pietilainen EP, Hiltunen JK & Hassinen IE (1981). Elimination and replenishment of tricarboxylic acid-cycle intermediates in myocardium. Biochem J 194, 867-875.
38. Odland LM, Howlett RA, Heigenhauser GJ, Hultman E & Spriet LL (1998). Skeletal muscle malonyl-CoA content at the onset of exercise at varyig power outputs in humans. Am J Physiol Endocrinol Metab 274, E1080-E1085.
39. Opie LH (1998). Heart Physiology: From Cell to Circulation, pp. 43-63. Lippincott-Raven Publishers, Philadelphia.
40. Oram JF, Bennetch SL & Neely JR (1973). Regulation of fatty acid utilization in isolated perfused hearts. J Biol Chem 248, 5299-5309.
41. Park H, Kaushik VK, Constant S, Prentki M, Przybytkowski E, Ruderman NB & Saha AK (2002). Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J Biol Chem 277, 32571-32577.
42. Passoneau JV & Lowry OH (1963). Phosphofructokinase and the control of the citric acid cycle. Biochem Biophys Res Commun 13, 372-379.
43. Poirier M, Vincent G, Reszko AE, Bouchard B, Kelleher JK, Brunengraber H & Des Rosiers C (2002). Probing the link between citrate and malonyl-CoA in perfused rate heart. Am J Physiol Heart Circ Physiol 283, H1379-H1386.
44. Randle PJ (1998). Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14, 263-283.
45. Rasmussen BB & Wolfe RR (1999). Regulation of fatty acid oxidation in skeletal muscle. Annu Rev Nutr 19, 463-484.
46. Reszko AE, Kasumov T, David F, Thomas KR, Jobbins KA, Cheng JF, Lopaschuk G, Dyck JRB, Diaz M, Rosiers CD, Stanley WC & Brunengraber H (2004). Regulation of malonyl-CoA concentration and turnover in the normal heart. J Biol Chem 279, 34298-34301.
47. Roden M (2004). How free fatty acids inhibit glucose utilization in human skeletal muscle. News Physiol Sci 19, 92-96.
48. Saddik M, Gamble J, Witters LA & Lopaschuk GD (1993). Acetyl-CoA carboxylase regulation of fatty acid oxidation in heart. J Biol Chem 268, 25836-25845.
49. Saks V, Dzeja P, Schlattner U, Vendlin M, Terzic A & Wallimann T (2006). Cardiac system bioenergetics: Metabolic basis for Frank-Starling law. J Physiol 571, 253-273.
50. Schonekess BO & Lopaschuk G (1995). The effects of carnitine on myocardial carbohydrate metabolism. In The Carnitine System: A New Therapeutical Approach to Cardiovascular Diseases, ed. DeJong JW & Ferrari R, pp. 39-52. Kluwer Academic Publishers, Dordrecht, Boston, London.
51. Stanley WC, Recchia FA & Lopaschuk GD (2005). Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85, 1093-1129.
52. Taegtmeyer H, Wilson CR, Razeghi P & Sharma S (2005). Metabolic energetics and genetics in the heart. Ann N Y Acad Sci 1047, 208-218.
53. Velot C, Mixon MB, Teige M & Srere PA (1997). Model of a quinary structure between Krebs TCA cycle enzymes: A model for the metabolon. Biochemistry 36, 14271-14276.
54. Wallimann T, Wyss M, Brdiczka D, Nicolay K & Eppenberger HM (1992). Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit'for cellular energy homeostasis. Biochem J 281, 21-40.
55. Williamson JR (1979). Mitochondrial function in the heart. Annu Rev Physiol 41, 485-506.
56. Williamson JR, Ford C, Illingworth J & Safer B (1976). Coordination of citric acid cycle activity with electron transport flux. Circ Res 38, I39-I51.
57. Winder WW & Hardie DG (1996). Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol Endocrinol Metab 270, E299-E304.
58. Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutber CA, Call GB, Clayton RD, Conley LM, Yoon S & Zhou B (1997). Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J Appl Physiol 82, 219-225.
59. Wolfgang MJ, Kurama T, Dai Y, Suwa A, Asaumi M, Matsumoto S, Cha SH, Shimokawa T & Lane MD (2006). The brain-specific carnitine palmitoultransferase regulates energy homeostasis. Proc Natl Acad Sci U S A 103, 7282-7287.